Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.14.13.9 extracted from

  • Cozzi, A.; Carpenedo, R.; Moroni, F.
    Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia (1999), J. Cereb. Blood Flow Metab., 19, 771-777.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
(m-nitrobenzoyl)-alanine mNBA, leads to an increase of L-kynurenine and kynurenic acid concentrations in the brain cortex after application in vivo Meriones unguiculatus
(m-nitrobenzoyl)-alanine mNBA, leads to an increase of L-kynurenine and kynurenic acid concentrations in the brain cortex after application in vivo Rattus norvegicus
3,4-dimethoxy-N-[4-(3-nitrophenyl)thiazol-2-yl]benzenesulfonamide leads to an increase of L-kynurenine and kynurenic acid concentrations in the brain cortex after application in vivo Meriones unguiculatus
3,4-dimethoxy-N-[4-(3-nitrophenyl)thiazol-2-yl]benzenesulfonamide leads to an increase of L-kynurenine and kynurenic acid concentrations in the brain cortex after application in vivo Rattus norvegicus

Organism

Organism UniProt Comment Textmining
Meriones unguiculatus
-
-
-
Rattus norvegicus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining